Skip to main content
. 2022 Jan 25;39(3):416–425. doi: 10.1111/echo.15304

TABLE 4.

Characteristics of the study population

Invasive group (n = 55) The whole cohort (n = 389) P
Age (IQR, year) 64 (5670.5) 64 (5572) .922
Male sex 17 (30.9%) 187(48.1%) .017
Body mass index (kg/m2) 24.3 ± .4 24.2 ± .2 .542
Medical history
Smoker 25(45.5%) 69(17.7%) <.001
Alcoholism 9(16.4%) 26(6.7%) .013
Hypertension 41(74.5%) 237 (60.9%) .051
Coronary disease 14(25.5%) 90(23.1%) .701
Diabetes 20 (36.4%) 89 (22.9%) .030
COPD 2 (3.6%) 10 (2.6%) .648
CKD (Stage ≥ 3) or ESRD 2 (3.6%) 26 (6.7%) .384
Laboratory
NT‐proBNP (pg/mL) 302 ± 94 871 ± 163 .002
Echocardiographic parameters
LV structure and function
LV end‐diastolic dimension (mm) 48 ± 1 48 ± 1 .217
LVMI (g/m2) 118 ± 5 117 ± 2 .718
RWT .43 ± .01 .41 ± .01 .072
LVEF (%) 66 ± 1 64 ± 1 .351
GLS (%) 18.6 ± .6 19.5 ± .2 .091
Doppler
Mitral E (IQR, cm/s) 67 (6077) 75 (6290.5) .004
Mitral A (IQR, cm/s) 81 (6996.5) 85 (70 101) .436
E/A ratio .9 ± .1 1.0 ± .1 .005
TR peak velocity (m/s) 2.4 ± .1 2.5 ± .1 <.001
Septal e′ velocity (cm/s) 6.3 ± .3 6.4 ± .1 .860
Lateral e′ velocity (cm/s) 9.0 ± .4 8.9 ± .2 .787
E/e′ ratio 9.4 ± .5 11.4 ± .3 .001
LA structure and function
LAVI (mL/m2) 27.5 ± 1.4 32.1 ± .7 .011
LAEF (%) 55 ± 1 54 ± 1 .426
LASr (%) 27.4 ± 1.1 27.3 ± .6 .823
LA strain derived index
LA filling index (%) 2.6 ± .1 3.4 ± .1 <.001
LA stiffness index .38 ± .03 .56 ± .04 <.001
LAVI/LASr 1.06 ± .06 1.54 ± .08 <.001

CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ESRD, end‐stage renal disease; GLS, left ventricular global longitudinal systolic strain; IQR, inter‐quartile ranges, LAEF, left atrial empty fraction; LASr, left atrium reservoir strain.; LAVI, left atrium maximal volume index; LV, left ventricle; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; RWT, relative wall thickness; TR, tricuspid regurgitation.